175 related articles for article (PubMed ID: 28219196)
1. [Treatment effects analysis of preoperative long-acting somatostatin analogs combined trans-sphenoidal endoscopic surgery for patients with growth hormone secreting pituitary macroadenomas].
Zhang LY; Deng K; Zhang Y; Yao Y; Zhu HJ; Jin ZM; Pan H
Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(5):375-379. PubMed ID: 28219196
[No Abstract] [Full Text] [Related]
2. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of trans-sphenoidal surgery in pituitary GH-secreting micro- and macroadenomas: a comparison between microsurgical and endoscopic approach.
Lenzi J; Lapadula G; D'amico T; Delfinis CP; Iuorio R; Caporlingua F; Mecca N; Mercuri V; Bassotti G; Rillo M; Santoro F; Tamburrano G; Santoro A; Gargiulo P
J Neurosurg Sci; 2015 Mar; 59(1):11-8. PubMed ID: 25658052
[TBL] [Abstract][Full Text] [Related]
4. Outcome of endoscopic transsphenoidal surgery in combination with somatostatin analogues in patients with growth hormone producing pituitary adenoma.
Zhou T; Wang F; Meng X; Ba J; Wei S; Xu B
J Korean Neurosurg Soc; 2014 Nov; 56(5):405-9. PubMed ID: 25535518
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
Taghvaei M; Sadrehosseini SM; Ardakani JB; Nakhjavani M; Zeinalizadeh M
World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance spectroscopy may serve as a presurgical predictor of somatostatin analog therapy response in patients with growth hormone-secreting pituitary macroadenomas.
Hu J; Yan J; Zheng X; Zhang Y; Ran Q; Tang X; Shu T; Shen R; Duan L; Zhang D; Guo Q; Zhang W; Yang H; Li S
J Endocrinol Invest; 2019 Apr; 42(4):443-451. PubMed ID: 30171531
[TBL] [Abstract][Full Text] [Related]
8. Comparison of endoscopic and microscopic trans-sphenoidal pituitary surgery: early results in a single centre.
Razak AA; Horridge M; Connolly DJ; Warren DJ; Mirza S; Muraleedharan V; Sinha S
Br J Neurosurg; 2013 Feb; 27(1):40-3. PubMed ID: 22834971
[TBL] [Abstract][Full Text] [Related]
9. A comparison between endoscopic trans-sphenoidal surgery and traditional trans-sphenoidal microsurgery for functioning pituitary adenomas.
Cheng RX; Tian HL; Gao WW; Li ZQ
J Int Med Res; 2011; 39(5):1985-93. PubMed ID: 22118003
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.
Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM
Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
12. Presurgical treatment with somatostatin analogues in growth hormone-secreting pituitary adenomas: A long-term single-center experience.
Lv L; Hu Y; Zhou P; Zhang S; Yin S; Zhang N; Jiang S
Clin Neurol Neurosurg; 2018 Apr; 167():24-30. PubMed ID: 29433055
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic endonasal trans-sphenoidal approach for pituitary adenomas: is one nostril enough?
Han S; Ding X; Tie X; Liu Y; Xia J; Yan A; Wu A
Acta Neurochir (Wien); 2013 Sep; 155(9):1601-9. PubMed ID: 23736939
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP; Shin BJ; Mubita L; Huang C; Anand VK; Boockvar JA; Schwartz TH
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[TBL] [Abstract][Full Text] [Related]
15. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.
Zhou H; Zha Z; Li X; Chen X; Wang J; Su Z
Neurosurg Rev; 2018 Jul; 41(3):869-875. PubMed ID: 29238923
[TBL] [Abstract][Full Text] [Related]
17. Preoperative somatostatin analogs treatment in acromegalic patients with macroadenomas. A meta-analysis.
Zhang L; Wu X; Yan Y; Qian J; Lu Y; Luo C
Brain Dev; 2015 Feb; 37(2):181-90. PubMed ID: 24815226
[TBL] [Abstract][Full Text] [Related]
18. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
19. The learning curve for endoscopic trans-sphenoidal resection of pituitary macroadenomas. A single institution experience, Leeds, UK.
Robins JMW; Alavi SA; Tyagi AK; Nix PA; Wilson TM; Phillips NI
Acta Neurochir (Wien); 2018 Jan; 160(1):39-47. PubMed ID: 29063272
[TBL] [Abstract][Full Text] [Related]
20. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
Duan L; Zhu H; Xing B; Gu F
BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
